Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.

Humphrey traveled from Michigan to Chicago to seek a second opinion at Northwestern Medicine in May 2024. A bronchoscopy ...

When Donna Rigby mentioned feeling winded walking from her car, her physician's decision to order a scan revealed early-stage ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Living with lung cancer often means spending more time in waiting rooms than in the moments that matter, but a new South ...

At the recent CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York Lung Cancer Symposium, Dr ...

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).

Lung cancer is the leading cause of cancer-related deaths in the United States. As we start Lung Cancer Awareness Month, a ...

Treatment innovations in advanced lung cancer and melanoma over the past 2 decades have significantly improved OS, but they ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...